Skip to main content
DNA Labs India

C9orf72 Gene Amyotrophic Lateral Sclerosis with Frontotemporal Dementia NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

C9orf72 Gene Amyotrophic Lateral Sclerosis with Frontotemporal Dementia NGS Genetic Test

Short Name: C9orf72 ALS-FTD NGS Test

Also known as: C9orf72 Gene Test, C9orf72 Repeat Expansion Test, ALS-FTD NGS Gene Test, C9orf72-associated ALS/FTD Genetic Test

C9orf72 Gene Amyotrophic Lateral Sclerosis with Frontotemporal Dementia NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are usually available within 3 to 4 weeks from sample receipt.. Free home collection in 300+ cities across India.

NGS Genetic TestAdult🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to detect disease-associated C9orf72 repeat expansions in patients with features of ALS/FTD or a family history of these conditions. The test helps confirm a genetic diagnosis, guides family counselling and enables at-risk relatives to make informed reproductive and clinical decisions.

Test Code
3896
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are usually available within 3 to 4 weeks from sample receipt.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation or fasting is required. A genetic counselling session before the test is advised to record clinical history and draw a family pedigree chart.

Method: Peripheral blood draw or FTA card blood spot or submitted extracted DNA

Step 2

Laboratory Analysis

A small amount of venous blood is collected, or one drop of blood is placed on an FTA card. If extracted DNA is being submitted, it is checked for adequacy before processing.

Step 3

Report Delivery

No dietary or activity restrictions are needed. The report will be shared after the defined turnaround time and a genetic counsellor will help explain the result.

Timeline: Reports are usually available within 3 to 4 weeks from sample receipt.

Patient Instructions

1
Before the Test:A pre-test genetic counselling discussion will cover the purpose, limitations, and possible outcomes of the test.
2
During the Test:The test uses NGS to analyse the C9orf72 gene from the submitted blood, FTA card spot, or extracted DNA sample.
3
After the Test:After the report is released, a post-test counselling session is recommended to review the result and its implications for the patient and family.

About This Test

Who Should Get This Test

The purpose of this test is to detect disease-associated C9orf72 repeat expansions in patients with features of ALS/FTD or a family history of these conditions. The test helps confirm a genetic diagnosis, guides family counselling and enables at-risk relatives to make informed reproductive and clinical decisions.

How to Prepare

  • No fasting is required.
  • Carry any previous neurology, MRI, or genetic reports.
  • Provide family history of ALS, FTD, dementia, or motor neuron disease.
  • Inform the lab if the patient has undergone allogeneic bone marrow transplantation or a recent blood transfusion.

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Genetic testing for C9orf72 should be considered when a neurologist finds upper or lower motor neuron dysfunction and features of frontotemporal dysfunction. Pre-test genetic counselling helps patients understand the implications of genetic results before testing."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs per lab protocol; one FTA blood spot or extracted DNA may also be accepted
ContainerEDTA vacutainer / sterile tube for extracted DNA / FTA card
Collection MethodPeripheral blood draw or FTA card blood spot or submitted extracted DNA

Sample Stability

Whole blood in EDTA: transport within 24–72 hours at 2–8°C.
FTA card blood spot: stable at room temperature once dried.
Extracted DNA: should be stored at -20°C or below.
Sample Rejection Criteria:
  • Insufficient sample volume
  • Haemolysed or clotted blood sample
  • Improperly labelled sample
  • FTA card not fully dried or contaminated
  • Missing clinical history or consent forms

Understanding Your Results

Results should be interpreted by a qualified clinician or genetic counsellor in the context of clinical presentation, family history, and other laboratory findings.
📊

No pathogenic C9orf72 repeat expansion detected

No evidence of C9orf72-associated ALS/FTD was found in the tested sample. Other genetic and non-genetic causes may need to be considered.

📊

Pathogenic C9orf72 repeat expansion detected

The result is consistent with C9orf72-associated ALS/FTD. Family members may benefit from predictive testing and genetic counselling.

📊

Variant of uncertain significance (VUS) identified

The clinical significance of the detected DNA change is currently unknown. Further segregation or functional studies may be needed.

⚠️ When to Consult a Doctor:

Consult a neurologist if you have progressive weakness, wasting, cramps, slurred speech, swallowing difficulty, or unexplained behavioural and cognitive changes. A genetic counsellor should be consulted before and after genetic testing.

Limitations

  • This test is designed to evaluate C9orf72 and may not detect other genetic causes of ALS or FTD.
  • NGS may not determine the exact length of very large C9orf72 repeat expansions.
  • A negative result does not rule out ALS/FTD caused by other genes or non-genetic factors.
  • C9orf72-related disorders have variable penetrance and expressivity; the test cannot predict exact age of onset or severity.
  • A variant of uncertain significance may be identified, requiring further family studies and clinical correlation.

Risks & Considerations

  • Minor bruising or discomfort at the blood collection site
  • Psychological stress related to result disclosure
  • Possibility of a variant of uncertain significance

Interfering Factors

  • Insufficient or degraded DNA can affect NGS performance.
  • Sample contamination during collection or handling may interfere with results.
  • Extremely large C9orf72 repeat expansions may require additional repeat-primed PCR for confirmation.
  • Recent bone marrow transplant from another individual can alter genetic test results.

Frequently Asked Questions

What is the C9orf72 gene test?
It is an NGS-based genetic test that analyses the C9orf72 gene to detect repeat expansions associated with amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD).
What is the cost of the C9orf72 ALS-FTD NGS test at DNA Labs India?
The test costs INR 20,000. It includes genetic counselling and support services. Free home sample collection is available for online bookings across many Indian cities.
Which sample is required for this test?
The accepted sample types are blood, extracted DNA, or one drop of blood on an FTA card.
Do I need to fast before this test?
No. Fasting is not required for the C9orf72 ALS-FTD NGS genetic test.
How long will the report take?
Reports are generally available in 3 to 4 weeks after the sample is received at the laboratory.
Who should consider this genetic test?
People with symptoms or a family history suggestive of ALS, FTD, or ALS-FTD may consider this test after evaluation by a neurologist and genetic counselling.
What does a positive C9orf72 result mean?
A pathogenic expansion in C9orf72 is associated with ALS/FTD. The result has implications for other family members, so genetic counselling is recommended.
Can C9orf72 cause both ALS and FTD?
Yes. C9orf72 repeat expansions are a major genetic cause of ALS, FTD, and the combined ALS-FTD syndrome.
Can this test predict when symptoms will start?
No. The test cannot predict the exact age of onset, severity, or disease course because C9orf72-related conditions show variable penetrance and expression.
Does DNA Labs India provide home sample collection for this test?
Yes. Free home sample collection is available for online bookings in selected cities across India.
Will insurance cover this test?
Insurance coverage is not guaranteed and depends on the policy, the diagnosis, and advance approval. Please check with your insurance provider.
What is the difference between ALS and FTD?
ALS mainly affects motor neurons, causing muscle weakness and wasting. FTD mainly affects the frontal and temporal brain lobes, causing behaviour, personality, and language changes. Some people have features of both.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.